Letter: Fecal VOCs in Lynch Syndrome: Sample Stability, Specificity and Statistical Validation
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | Xidi Yang, Yue Wang, Fa Tian |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2026
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Faecal Volatile Organic Compounds to Detect Colorectal Neoplasia in Lynch Syndrome—A Prospective Longitudinal Multicentre Study
por: Elsa L. S. A. van Liere, et al.
Publicado: (2024)
por: Elsa L. S. A. van Liere, et al.
Publicado: (2024)
Stability of Classification Systems for Irritable Bowel Syndrome
por: Mais Khasawneh, et al.
Publicado: (2025)
por: Mais Khasawneh, et al.
Publicado: (2025)
Letter: Is Enteric Neuropathy Absent in Hypermobility Spectrum Disorders/Hypermobile Ehler–Danlos Syndrome? Authors' Reply
por: Kim W. E. Sweerts, et al.
Publicado: (2025)
por: Kim W. E. Sweerts, et al.
Publicado: (2025)
Letter: The Essential Role of Social Workers in Reducing Socioeconomic Disparities in Chronic Liver Disease
por: Qiong Yi, et al.
Publicado: (2024)
por: Qiong Yi, et al.
Publicado: (2024)
Letter: Prospective Individualised Validation of the GES in Predicting Hepatocellular Carcinoma—A ‘Precision Medicine’ Study
por: Ahmed Helmy
Publicado: (2025)
por: Ahmed Helmy
Publicado: (2025)
Letter: Prospective Individualised Validation of the GES in Predicting Hepatocellular Carcinoma—A ‘Precision Medicine’ Study: Authors' Reply
por: Gamal Shiha, et al.
Publicado: (2025)
por: Gamal Shiha, et al.
Publicado: (2025)
Validating Simple Modifications to the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care
por: Vivek C. Goodoory, et al.
Publicado: (2024)
por: Vivek C. Goodoory, et al.
Publicado: (2024)
Letter: From Descriptive Epidemiology to Clinical Imperative—Challenging the Paradigm of Pain and Sedative Use in Inflammatory Bowel Disease
por: DuJiang Yang, et al.
Publicado: (2025)
por: DuJiang Yang, et al.
Publicado: (2025)
Letter: The Hidden Truth of IBD Risk—From Antibiotics to Environmental Factors
por: Xueneng Yang, et al.
Publicado: (2025)
por: Xueneng Yang, et al.
Publicado: (2025)
Letter: Attempted Validation of Villin‐1 as a Gut Barrier Marker in Decompensated Cirrhosis—Potential Confounding by Tubular Injury and Aetiology. Authors' Reply
por: David Tornai, et al.
Publicado: (2026)
por: David Tornai, et al.
Publicado: (2026)
Letter: Association Between Viral Replication Activity and Postoperative Recurrence of HBV‐Related Hepatocellular Carcinoma
por: Sifu Yang
Publicado: (2025)
por: Sifu Yang
Publicado: (2025)
Letter: Methodological Flaws and Clinical Gaps—A Critique of TAF / TDF 5‐Year Data in East Asian CHB
por: Zhiyao Shi, et al.
Publicado: (2025)
por: Zhiyao Shi, et al.
Publicado: (2025)
Letter: Myokines Are Also Associated With Disease Course in Primary Biliary Cholangitis
por: Leyu Zhou, et al.
Publicado: (2024)
por: Leyu Zhou, et al.
Publicado: (2024)
Letter: Risks of proton pump inhibitor treatment in cirrhotic patients
por: Jiamei Wang, et al.
Publicado: (2024)
por: Jiamei Wang, et al.
Publicado: (2024)
Letter: Reflections on the significance of myokines in alcohol‐associated liver disease
por: Yaomin Wang, et al.
Publicado: (2024)
por: Yaomin Wang, et al.
Publicado: (2024)
Letter: From Regional Diagnostic Thresholds to Phenotype‐Guided Management in Asian Reflux Disease
por: Jiahao Liu, et al.
Publicado: (2026)
por: Jiahao Liu, et al.
Publicado: (2026)
Letter: Interpreting Apparent P‐ CAB Superiority for Antithrombotic‐Associated Upper Gastrointestinal Bleeding
por: Xiaoqing Yang, et al.
Publicado: (2026)
por: Xiaoqing Yang, et al.
Publicado: (2026)
Letter: Towards Better Intervention Strategies for MASLD and MetALD—What Are We Missing?
por: Qiang Hu, et al.
Publicado: (2024)
por: Qiang Hu, et al.
Publicado: (2024)
Letter: Is Routine ECG Monitoring Redundant During Terlipressin Therapy in HRS ‐ AKI ?
por: Xing Wang
Publicado: (2025)
por: Xing Wang
Publicado: (2025)
Letter: Are All Extra‐Digestive Cancer Signals in Inflammatory Bowel Disease Telling the Same Story?
por: Liang Jiao, et al.
Publicado: (2026)
por: Liang Jiao, et al.
Publicado: (2026)
Letter: Intestinal Ultrasound‐Prioritising Progress
por: Kacie H. Denton, et al.
Publicado: (2026)
por: Kacie H. Denton, et al.
Publicado: (2026)
Letter: Irritable bowel syndrome and antibiotics
por: George F. Longstreth
Publicado: (2024)
por: George F. Longstreth
Publicado: (2024)
Letter: Shifting focus—From ChatGPT to specialised medical LLMs
por: Shuo Wang, et al.
Publicado: (2024)
por: Shuo Wang, et al.
Publicado: (2024)
Letter: Double PBC ‐Related Autoantibody Positivity—How Essential Is It for Diagnosis? Authors' Reply
por: Hong‐Li Liu, et al.
Publicado: (2026)
por: Hong‐Li Liu, et al.
Publicado: (2026)
Letter: Addressing Gaps in Hospital‐Based Hepatitis C Screening—Insights and Recommendations
por: Zhen Deng, et al.
Publicado: (2025)
por: Zhen Deng, et al.
Publicado: (2025)
Letter: Reflections on the role of over‐the‐scope clips in high‐risk upper gastrointestinal bleeding
por: Yajie Wang, et al.
Publicado: (2024)
por: Yajie Wang, et al.
Publicado: (2024)
Letter: Potential confounders might exaggerate the risk of rheumatoid arthritis in patients with microscopic colitis
por: Fang Yan, et al.
Publicado: (2024)
por: Fang Yan, et al.
Publicado: (2024)
Letter: Steroid Tapering—Is Shorter Duration Better?
por: Juntao Lu, et al.
Publicado: (2026)
por: Juntao Lu, et al.
Publicado: (2026)
Letter: Resmetirom for treatment of MASH with children and adolescents
por: Yong‐Hai Zhou, et al.
Publicado: (2024)
por: Yong‐Hai Zhou, et al.
Publicado: (2024)
Letter: Differences in Disease Characteristics and Treatment Exposures Between Paediatric and Adult‐Onset IBD
por: Xinli Chen, et al.
Publicado: (2024)
por: Xinli Chen, et al.
Publicado: (2024)
Letter: Association Between Viral Replication Activity and Postoperative Recurrence of HBV‐Related Hepatocellular Carcinoma—Authors' Reply
por: Jiwon Yang, et al.
Publicado: (2025)
por: Jiwon Yang, et al.
Publicado: (2025)
Letter: Impact of antiviral treatment on renal function in patients with chronic hepatitis B
por: Jian Wang, et al.
Publicado: (2024)
por: Jian Wang, et al.
Publicado: (2024)
Letter: Post‐HCV Cure, Precision Assessment of Liver Stiffness and Diabetes Risk in Maternal Populations—A Critical Research Need
por: Zihe Guan, et al.
Publicado: (2025)
por: Zihe Guan, et al.
Publicado: (2025)
Letter: Incremental Value and Stratified Interpretation of Dual Autoantibody Positivity in Primary Biliary Cholangitis. Authors' Reply
por: Hong‐Li Liu, et al.
Publicado: (2026)
por: Hong‐Li Liu, et al.
Publicado: (2026)
Letter: Reinterpreting the Role of Microbiota‐Driven Nitric Oxide in Cirrhotic Portal Hypertension—A Maladaptive Compensatory Response?
por: Meiyu Yang, et al.
Publicado: (2025)
por: Meiyu Yang, et al.
Publicado: (2025)
Letter: Therapeutic Targeting of PPARs in PBC —Additional Considerations
por: Christophe Corpechot
Publicado: (2026)
por: Christophe Corpechot
Publicado: (2026)
Letter: Temporal Trends in the Rate of Colectomy in Ulcerative Colitis
por: Richard Pollok
Publicado: (2025)
por: Richard Pollok
Publicado: (2025)
Letter: Helicobacter pylori and Eosinophilic Oesophagitis—Lost in Definition?
por: Fernanda Cristofori, et al.
Publicado: (2025)
por: Fernanda Cristofori, et al.
Publicado: (2025)
Letter: Irritable bowel syndrome and antibiotics—Authors' reply
por: Kyle Staller, et al.
Publicado: (2024)
por: Kyle Staller, et al.
Publicado: (2024)
Letter: Toward Intra‐Class Switching With JAK Inhibitors?
por: Mathieu Uzzan, et al.
Publicado: (2025)
por: Mathieu Uzzan, et al.
Publicado: (2025)
Ejemplares similares
-
Faecal Volatile Organic Compounds to Detect Colorectal Neoplasia in Lynch Syndrome—A Prospective Longitudinal Multicentre Study
por: Elsa L. S. A. van Liere, et al.
Publicado: (2024) -
Stability of Classification Systems for Irritable Bowel Syndrome
por: Mais Khasawneh, et al.
Publicado: (2025) -
Letter: Is Enteric Neuropathy Absent in Hypermobility Spectrum Disorders/Hypermobile Ehler–Danlos Syndrome? Authors' Reply
por: Kim W. E. Sweerts, et al.
Publicado: (2025) -
Letter: The Essential Role of Social Workers in Reducing Socioeconomic Disparities in Chronic Liver Disease
por: Qiong Yi, et al.
Publicado: (2024) -
Letter: Prospective Individualised Validation of the GES in Predicting Hepatocellular Carcinoma—A ‘Precision Medicine’ Study
por: Ahmed Helmy
Publicado: (2025)